236 related articles for article (PubMed ID: 4150143)
21. [Somatic disorders during long-term drug treatment of schizophrenic patients].
vom Brocke I
Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663
[No Abstract] [Full Text] [Related]
22. Extrapyramidal motor disorders due to toxic effect of phenothiazines.
Tikare SK; Tikare SS
J Indian Med Assoc; 1972 Jan; 58(2):39-42. PubMed ID: 5017799
[No Abstract] [Full Text] [Related]
23. General principles of treatment of extrapyramidal syndromes.
Gelenberg AJ
Clin Neuropharmacol; 1983; 6 Suppl 1():S52-6. PubMed ID: 6139166
[No Abstract] [Full Text] [Related]
24. Dystonia, neuroleptic dose, and anticholinergic drugs.
McEvoy JP; Simpson GM
Am J Psychiatry; 1987 Mar; 144(3):393-4. PubMed ID: 2881496
[No Abstract] [Full Text] [Related]
25. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects.
Keepers GA; Casey DE
Am J Psychiatry; 1991 Jan; 148(1):85-9. PubMed ID: 1670616
[TBL] [Abstract][Full Text] [Related]
26. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
Bordeleau JM; Tétreault L; Elie R
Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
[No Abstract] [Full Text] [Related]
27. [The antipsychotic action of neuroleptics and basal ganglia function].
Arushanian EB
Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
[No Abstract] [Full Text] [Related]
28. [Extrapyramidal symptoms following Clozapine therapy. Case report].
Doepp S; Buddeberg C
Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
[No Abstract] [Full Text] [Related]
29. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Klett CJ; Caffey E
Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
[No Abstract] [Full Text] [Related]
30. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced extrapyramidal symptoms: their incidence and treatment.
Sheppard C; Merlis S
Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
[No Abstract] [Full Text] [Related]
32. [Experience with using amedin in children with movement disorders of extrapyramidal and labyrinth origin].
Panfilova ZP; Kaganova ED; Skubak VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1495-7. PubMed ID: 716725
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acute neuroleptic-induced movement disorders.
Tonda ME; Guthrie SK
Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
[TBL] [Abstract][Full Text] [Related]
34. Structure side-effect sorting of drugs. I. Extrapyramidal syndrome.
Lien EJ; Gudauskas GA
J Pharm Sci; 1973 Apr; 62(4):645-7. PubMed ID: 4698989
[No Abstract] [Full Text] [Related]
35. The extrapyramidal neuroleptic syndrome: description and measurement.
Elie R; Gagnon MA; Lamontagne Y; Tetreault L
Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
[No Abstract] [Full Text] [Related]
36. [Specific therapy of extrapyramidal-motor syndromes].
Hartmann-von Monakow K
Bibl Psychiatr Neurol; 1969; 139():705-11. PubMed ID: 4257724
[No Abstract] [Full Text] [Related]
37. Drug-induced extrapyramidal disorders.
Chase TN
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954
[No Abstract] [Full Text] [Related]
38. Prevention and management of tardive dyskinesia.
Crane GE
Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149
[No Abstract] [Full Text] [Related]
39. The pharmacology of extrapyramidal movement disorders.
Klawans HL
Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
[No Abstract] [Full Text] [Related]
40. Extrapyramidal effects of neuroleptics.
Korczyn AD; Goldberg GJ
J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):866-9. PubMed ID: 11277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
